Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 07, 2023 16:05 ET | Source: Aruna Bio

Aruna Bio Announces Preclinical Results from Pilot Study Evaluating AB126 for the Treatment of Amyotrophic Lateral Sclerosis

- Data from superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS) mouse model demonstrated prolonged survival and reduced inflammation in the spinal cord – -AB126, an unmodified exosome...
September 05, 2023 16:05 ET | Source: Aruna Bio

Aruna Bio Announces Presentation on Treatment Opportunities for its Neural Exosome Platform and Lead Program, AB126 at the Exosome Based Therapeutic Development Summit

- Preclinical data demonstrates AB126, an unmodified exosome derived from neural stem cells, shows native therapeutic activity and evidence of anti-inflammatory and neuroprotective properties – -...
August 15, 2023 08:00 ET | Source: Aruna Bio

Aruna Bio Announces Oral Presentation on Treatment Opportunities of Lead Program, AB126 at the Exosome Based Therapeutic Development Summit and Applications of Exosomes BioProcess International Conference & Exhibition

BOSTON and ATHENS, Ga., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today...
March 28, 2023 08:00 ET | Source: Aruna Bio

Aruna’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Receives Entrepreneur Distinction from The University System of Georgia Board of Regents

BOSTON and ATHENS, Ga., March 28, 2023 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today...
December 19, 2022 08:00 ET | Source: Aruna Bio

Aruna Bio Announces Appointment of Mike Ryan to its Board of Directors

BOSTON and ATHENS, Ga., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today...
October 06, 2022 08:00 ET | Source: Aruna Bio

Aruna Bio Announces Presentation on Neural Exosome Treatment Opportunities and Lead Program, AB126 at Exosome Based Therapeutic Development Summit

-AB126 is an unmodified exosome derived from neural stem cell lines with the innate ability to cross the blood-brain-barrier- -Preclinical data demonstrate the potential therapeutic activity of AB126...
April 14, 2021 08:00 ET | Source: Aruna Bio

Aruna Bio Closes $10.8 Million Common Stock Financing

ATHENS, Ga. and RESEARCH TRIANGLE PARK, N.C., April 14, 2021 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases,...
May 26, 2020 07:00 ET | Source: Aruna Bio

Aruna Bio to Present at the Jefferies 2020 Healthcare Conference

ATHENS, Ga. and RESEARCH TRIANGLE PARK, N.C., May 26, 2020 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today...